CLB
Core Laboratories NV
10.40$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -71.5% | +210.1% | -23.6% | +57.4% | -67.7% | +109.1% | -38.9% | -6.5% | -50.1% | +96.9% | – | |
| – | -1.4% | -0.8% | -1.9% | -2.5% | -0.3% | +1.4% | -1.3% | -2.1% | +2.1% | +2.6% | +1.6% | – | |
| – | -24.4% | +208.0% | -102.7% | – | – | – | -87.1% | +146.5% | -16.0% | +351.7% | -82.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -205.9% | – | -110.8% | – | -125.9% | – | -343.9% | – | – | – | – | |
| – | -25.8% | +18.5% | -6.2% | -4.9% | +60.7% | -18.3% | +20.9% | -29.9% | +25.3% | +28.7% | +17.9% | – | |
| – | -28.3% | -32.3% | -58.5% | -28.5% | +624.8% | – | -313.0% | – | -256.8% | -9.6% | +15.9% | – | |
| – | -0.6% | +0.2% | +0.4% | -0.2% | +0.0% | +0.0% | +0.0% | -0.9% | +0.2% | -1.3% | +0.0% | – | |
| – | +718.3% | -97.5% | +268.2% | +21.0% | +2,402.0% | -58.8% | +35.5% | +82.9% | -47.0% | +50.5% | -32.7% | – | |
| – | – | – | – | – | +75.0% | -85.7% | -100.0% | – | -55.6% | – | -115.6% | – | |
| – | +206.4% | -77.9% | +235.2% | -35.5% | +119.5% | -76.9% | -28.6% | +414.5% | -56.7% | -93.6% | +767.0% | – | |
| – | – | – | – | +35.8% | -161.3% | – | +207.8% | -161.2% | – | – | -171.8% | – | |
| – | – | -85.3% | +477.0% | -27.4% | +56.5% | -81.0% | +211.4% | -43.0% | -24.2% | -122.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.